Literature DB >> 3118664

[Prophylactic intravesical chemotherapy in bladder tumors after surgery of upper tract urothelial carcinoma].

K Tari1, I Satake, S Kojima, T Negishi, K Yoshida, Y Nakame, F Kanaoya, S Horiuchi, T Saito, F Owada.   

Abstract

Sixteen patients with upper tract urothelial carcinoma underwent intravesical chemotherapy usually at 2 week intervals in the first year and at 4 week intervals in the second year after nephrouretectomy. For bladder instillation 10 mg mitomycin C in 20 ml saline was used on 7 patients, 5 mg carboquone and 100 mg cytosine arabinoside in 40 ml saline on 5 patients and 30 mg adriamycin in 40 ml saline on 4 patients. Two (12.5%) of the 16 patients developed bladder tumors within 2 years after surgery, but 11 (42.3%) of the 26 patients with upper tract urothelial carcinoma who did not receive intravesical chemotherapy suffered from bladder tumor within 2 years after surgery. Prophylactic intravesical chemotherapy reduced significantly (p less than 0.1) the incidence of bladder tumor after the surgery of renal pelvic and ureteral tumors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3118664

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  2 in total

1.  Prognostic value and efficacy valuation of postoperative intravesical instillation in primary urothelial carcinomas of upper urinary tract.

Authors:  Xiaheng Deng; Xiao Yang; Yidong Cheng; Xuzhong Liu; Bian Wu; Zijie Wang; Zhengkai Huang; Kang Liu; Ruizhe Zhao; Jun Wang; Qiang Lu; Chao Qin; Changjun Yin
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  The nephroureterectomy: a review of technique and current controversies.

Authors:  Gregory J Barton; Wei Phin Tan; Brant A Inman
Journal:  Transl Androl Urol       Date:  2020-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.